Related Experiment Video
Updated: Apr 10, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
Australian vaccine preventable disease epidemiological review series: mumps 2008-2012
Shopna K Bag1, Aditi Dey1, Han Wang1
1National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead and the University of Sydney, Westmead, New South Wales.
Abstract:
In 2007, Australia recorded the highest notification rate (2.8 per 100,000) for mumps since it became notifiable, with outbreaks in Western Australia and the Northern Territory. Of particular concern was the number of cases seen in vaccinated individuals. The aim of this study was to review subsequent epidemiological data. Notification, hospitalisation and mortality data from the National Notifiable Diseases Surveillance System, the National Hospital Morbidity Database and Australian Bureau of Statistics (ABS) respectively, from 2008 to 2012 for notifications and 2008 to 2011 for hospitalisations and deaths, were analysed by age, year and jurisdiction. ABS population data were used to calculate rates. National mumps notification rates decreased from 1.3 per 100,000 in 2008 to 0.4 per 100,000 in 2010, but then increased to 0.9 per 100,000 in 2012, predominantly due to increased notifications in New South Wales (1.4 per 100,000). Hospitalisation rates remained stable at 0.4 per 100,000 over the 2008-2011 period. The median age of notified cases was 30 years and for hospitalisations, 27 years. The highest rate of notifications and hospitalisations was in the 25-34 years age group. Completeness of vaccination status ranged from 16% to 39%. The increasing trend in mumps notifications needs to be closely monitored. Improved data quality, in particular on vaccination status, is needed to inform the monitoring of vaccine effectiveness. In March 2014 the World Health Organization certified that Australia had achieved measles elimination. Greater availability of case history (vaccination status and place of acquisition) and genotyping data would facilitate an assessment of Australia's progress in relation to mumps elimination.
Insights
Mumps notifications in Australia decreased then increased, with a concerning rise in vaccinated individuals. Better vaccination data is crucial for monitoring vaccine effectiveness and potential mumps elimination.
Area of Science:
- Epidemiology
- Infectious Disease Surveillance
- Public Health
Background:
- Australia experienced a notable increase in mumps notifications in 2007, with outbreaks in Western Australia and the Northern Territory.
- A significant concern was the occurrence of mumps cases in individuals who had been vaccinated.
Purpose of the Study:
- To analyze epidemiological data on mumps in Australia from 2008 to 2012.
- To assess trends in mumps notifications, hospitalizations, and mortality.
- To identify demographic patterns and inform strategies for mumps control.
Main Methods:
- Utilized data from the National Notifiable Diseases Surveillance System, National Hospital Morbidity Database, and Australian Bureau of Statistics (ABS).
- Analyzed notification, hospitalization, and mortality data from 2008-2012 (notifications) and 2008-2011 (hospitalizations/deaths) by age, year, and jurisdiction.
- Calculated rates using ABS population data.
Main Results:
- National mumps notification rates declined from 1.3/100,000 in 2008 to 0.4/100,000 in 2010, then rose to 0.9/100,000 in 2012, driven by New South Wales.
- Hospitalization rates remained stable at 0.4/100,000 between 2008-2011.
- The median age for cases and hospitalizations was 30 and 27 years, respectively, with the 25-34 age group most affected. Vaccination status completeness was low (16%-39%).
Conclusions:
- The increasing trend in mumps notifications requires close monitoring.
- Improved data quality, particularly regarding vaccination status, is essential for evaluating vaccine effectiveness.
- Enhanced case history and genotyping data are needed to assess Australia's progress toward mumps elimination.
Related Concept Videos
Vaccinations
Investigation of Disease Outbreaks
Viral Meningitis
Infectious Diseases and Their Occurrence
Influenza

